Rocket Lab's stock has dropped recently despite a growing backlog and a major acquisition on the horizon. The company reported record Q2 revenue of $234 million, a 62% increase year-over-year, and a backlog of $2.36 billion. The upcoming Neutron rocket launch and the Iridium deal are pivotal events that could significantly impact the stock's trajectory. Analysts project a price target of $120.99, implying a 95% upside from the current price, but caution remains due to potential delays and high valuation risks.
Rocket Lab and AST SpaceMobile both reported Q2 2026 earnings, aiming to disrupt SpaceX in different ways. Rocket Lab posted $234 million in revenue, up 62%, with a $2.36 billion backlog and strong defense contracts, showing a diversified business mo...
SpaceX stock fell 5% following the release of a $47.2 billion tranche of insider shares becoming sellable after the company's IPO lockup period. This large supply overhang pressured not only SpaceX but also other space-related stocks like AST SpaceMo...
Rocket Lab Corporation (RKLB) is rated a Buy with a 24% upside potential due to key growth drivers like the upcoming Neutron rocket launch in Q4 2026, the acquisition of Iridium Communications, and a strong backlog. The company reported a 62% year-ov...
Rocket Lab's stock was upgraded to a bullish rating following a more than 40% pullback and improved fundamentals. The company reported record Q2 revenue of $234.07 million, a 62% increase year-over-year, supported by a strong backlog indicating solid...
SpaceX shares rose 4% following Pivotal Research's initiation of coverage with a Buy rating and a $220 price target, significantly above current levels. The boost reflects strong growth in SpaceX's AI compute, Starlink, and launch businesses, with Q2...
